Company Advanced Oncotherapy PLC London S.E.
Equities
GB00B16JQ761
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- GBX | - |
Apr. 02 | Sareum ups retail offer; SThree nabs former ITV exec | AN |
Feb. 02 | Advanced Oncotherapy eyes USD15 million tranche in February | AN |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 14-08-26 | |
Director of Finance/CFO | - | 16-09-30 | |
Michael Sinclair
CHM | Chairman | 82 | 06-06-15 |
Jonathan Farr
CTO | Chief Tech/Sci/R&D Officer | - | 17-06-13 |
Ed Lee
COO | Chief Operating Officer | - | 17-01-31 |
David Navas
IRC | Investor Relations Contact | - | - |
Henry Clarke
SEC | Corporate Secretary | - | 19-05-18 |
Bridget Biggar
HRO | Human Resources Officer | - | 16-10-31 |
Graham Pughe
AUD | Comptroller/Controller/Auditor | - | 12-11-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lori Jo Cross
BRD | Director/Board Member | 64 | 20-09-28 |
Michael Sinclair
CHM | Chairman | 82 | 06-06-15 |
Hans von Celsing
BRD | Director/Board Member | 74 | 17-01-25 |
Director/Board Member | 73 | 13-09-30 | |
Ren Hua Zhang
BRD | Director/Board Member | 58 | 18-08-27 |
Director/Board Member | 72 | 13-04-25 | |
Director/Board Member | 74 | 17-02-08 | |
Chief Executive Officer | 49 | 14-08-26 | |
Stephen Myers
BRD | Director/Board Member | 78 | 17-01-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 542,573,869 | 284,689,154 ( 52.47 %) | 0 | 52.47 % |
Company contact information
Advanced Oncotherapy Plc
4 Tenterden Street Third Floor
W1S 1TE, London
+44 20 3617 8728
http://advancedoncotherapy.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+8.82% | 219B | |
+7.37% | 183B | |
+11.36% | 133B | |
+25.54% | 108B | |
+0.76% | 63.06B | |
+12.79% | 52.02B | |
-0.62% | 48.2B | |
-0.08% | 40.37B | |
+13.20% | 39.35B |
- Stock Market
- Equities
- AVO Stock
- Stock
- Company Advanced Oncotherapy PLC